W J B van Wamel
Overview
Explore the profile of W J B van Wamel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
449
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pirzadian J, Souhoka T, Herweijer M, van Heel L, van Wamel W, Goossens R, et al.
J Hosp Infect
. 2022 May;
127:39-43.
PMID: 35577265
In hospitals, sinks act as reservoirs for bacterial pathogens. To assess the extent of splashing, fluorescein dye was added to four hospital sinks previously involved in pathogen dispersal to the...
2.
Lekkerkerk W, van Wamel W, Snijders S, Willems R, van Duijkeren E, Broens E, et al.
J Clin Microbiol
. 2015 Mar;
53(6):1836-41.
PMID: 25809975
Fifteen percent of all methicillin-resistant Staphylococcus aureus (MRSA) clonal complex 398 (CC398) human carriers detected in The Netherlands had not been in direct contact with pigs or veal calves. To...
3.
Heikema A, Jacobs B, Horst-Kreft D, Huizinga R, Kuijf M, Endtz H, et al.
Clin Microbiol Infect
. 2012 Nov;
19(2):E106-12.
PMID: 23173866
Due to molecular mimicry, Campylobacter jejuni lipo-oligosaccharides can induce a cross-reactive antibody response to nerve gangliosides, which leads to Guillain-Barré syndrome (GBS). Cross-reactive antibodies to ganglioside GQ1b are strongly associated...
4.
Lekkerkerk W, Van de Sande-Bruinsma N, van der Sande M, Tjon-A-Tsien A, Groenheide A, Haenen A, et al.
Clin Microbiol Infect
. 2011 Oct;
18(7):656-61.
PMID: 21967090
The Netherlands is known for its low methicillin-resistant Staphylococcus aureus (MRSA) prevalence. Yet MRSA with no link to established Dutch risk factors for acquisition, MRSA of unknown origin (MUO), has...
5.
Verkaik N, Nguyen D, de Vogel C, Moll H, Verbrugh H, Jaddoe V, et al.
Clin Microbiol Infect
. 2011 Sep;
17(12):1840-4.
PMID: 21883660
It remains largely unknown which factors determine the clinical outcome of human metapneumovirus (HMPV) infections. The aim of the present study was to analyse whether exposure to bacterial pathogens can...
6.
Manenschijn L, Jetten A, van Wamel W, Tavakol M, Koper J, van den Akker E, et al.
Eur J Clin Microbiol Infect Dis
. 2011 May;
31(1):97-100.
PMID: 21573817
Staphylococcus aureus (S. aureus) colonizes the anterior nares in part of the population and the persistent carrier state is associated with increased infection risk. Knowledge concerning the determinants of S....
7.
Shoma S, Verkaik N, de Vogel C, Hermans P, van Selm S, Mitchell T, et al.
Eur J Clin Microbiol Infect Dis
. 2010 Nov;
30(4):521-6.
PMID: 21086008
Presently, several pneumococcal proteins are being evaluated as potential vaccine candidates. Here, we gather novel insights in the immunogenicity of PLY, PsaA, PspA, PspC, NanA, Hyl, PpmA, SlrA, Eno, IgA1-protease,...
8.
Verkaik N, Benard M, Boelens H, de Vogel C, Nouwen J, Verbrugh H, et al.
Clin Microbiol Infect
. 2010 Apr;
17(3):343-8.
PMID: 20370801
The Staphylococcus aureus immune evasion cluster (IEC), located on β-haemolysin-converting bacteriophages (βC-Φs), encodes the immune-modulating proteins chemotaxis inhibitory protein, staphylococcal complement inhibitor (SCIN), staphylococcal enterotoxin A and staphylokinase. Its precise...
9.
Verkaik N, Boelens H, de Vogel C, Tavakol M, Bode L, Verbrugh H, et al.
Eur J Clin Microbiol Infect Dis
. 2010 Feb;
29(5):509-18.
PMID: 20186449
Expanding knowledge on the humoral immune response in Staphylococcus aureus-infected patients is a mandatory step in the development of vaccines and immunotherapies. Here, we present novel insights into the antibody...
10.
Verkaik N, Lebon A, de Vogel C, Hooijkaas H, Verbrugh H, Jaddoe V, et al.
Clin Microbiol Infect
. 2009 Oct;
16(8):1312-7.
PMID: 19832714
In order to develop novel antistaphylococcal strategies, understanding the determinants of carriage and how humans respond to Staphylococcus aureus exposure is essential. Here, the primary S. aureus-specific humoral immune response...